Platelet-derived growth factor induces fetal wound fibrosis

J Pediatr Surg. 1994 Nov;29(11):1405-8. doi: 10.1016/0022-3468(94)90130-9.

Abstract

The fetal response to cutaneous injury differs markedly from that of the adult, proceeding with only minimal inflammation, minimal fibroblast proliferation, and only essential collagen deposition. Although the sequence of events in adult wound healing is well defined and thought to be controlled in part by potent polypeptide cytokines, relatively sparse information exists regarding growth factor involvement in fetal wound repair. Thus, the authors sought to examine the effect of platelet-derived growth factor (PDGF), a putative adult wound healing regulator, on the cellular and extracellular matrix events at a fetal wound site. SILASTIC wound implants containing 0, 1.0, 5.0, or 10.0 ng of human PDGF were placed subcutaneously on the backs of 24-day-gestation fetal rabbits (full term, 31 days) and then harvested after either 1, 3, or 5 days in utero. The specimens underwent standard histological processing and were evaluated in a blinded fashion. Compared with controls, PDGF-treated implants had a marked increase in acute inflammation, fibroblast recruitment, and collagen and hyaluronic acid deposition; these differences appeared to be largely time- and PDGF dose-dependent. Thus, the fetal system is responsive to an adult wound healing mediator, and these data suggest that fetal repair proceeds in the absence of PDGF.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Dose-Response Relationship, Drug
  • Fetus / pathology
  • Fetus / physiology*
  • Fibrosis
  • Platelet-Derived Growth Factor / administration & dosage
  • Platelet-Derived Growth Factor / pharmacology*
  • Prostheses and Implants
  • Rabbits
  • Silicone Elastomers
  • Wound Healing / drug effects*
  • Wound Healing / physiology

Substances

  • Platelet-Derived Growth Factor
  • Silicone Elastomers